ERS Respiratory Channel

CDN Connection Issue

It appears that your current network does not allow connection to the CDN (Content Delivery Network) required for this service to function properly.

To resolve this issue, please try the following actions :

• Contact your network administrator : Inform them of this restriction so they can adjust the network settings accordingly.

• Use another network : Try connecting from a different network, such as another Wi-Fi network or a mobile connection.

We apologize for the inconvenience and thank you for your understanding.

Abstract

Background
Both bronchoscopic lung volume reduction with endobronchial valves (BLVR-EBV) and pulmonary rehabilitation (PR) are effective treatments for improving exercise capacity and patient-reported outcomes in patients with severe Chronic Obstructive Pulmonary Disease (COPD).

Aim
To study the impact and timing of PR in patients who underwent BLVR-EBV.

Methods
We included patients with severe COPD who were eligible for BLVR-EBV and PR. Participants were randomized into three groups: PR before BLVR-EBV, PR after BLVR-EBV, or BLVR-EBV without PR. The primary outcome was change in constant work rate cycle test (CWRT) endurance time at 6-month follow-up between the PR groups and BLVR-EBV only group. Secondary endpoints included changes in six-minute walking test, daily step count, and patient-reported outcomes.

Results
Ninety-seven participants were included. At 6-month follow-up, there was no difference in change in CWRT endurance time between the PR groups and BLVR-EBV alone (median: 376 [IQR: 26; 906] vs. 601 [73; 1003] seconds, p=0.416) or any of the secondary endpoints. Similarly, we found no differences in change in CWRT endurance time between the groups that underwent PR before and after BLVR-EBV (421 [44; 1304] vs. 292 [17; 630] seconds, p=0.210) or in the secondary endpoints.

Conclusion
The combination of PR and BLVR-EBV did not result in increased exercise capacity, daily step count, or improved patients-reported outcomes compared to BLVR-EBV alone. The timing of PR in relation to BLVR-EBV did not affect treatment efficacy.

Abstract

#{title}